-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Reiterates Sector Perform on Aardvark Therapeutics, Maintains $6 Price Target

Benzinga·09/24/2026 13:29:02
Diffusion vocale
RBC Capital analyst Brian Abrahams reiterates Aardvark Therapeutics (NASDAQ:AARD) with a Sector Perform and maintains $6 price target.